The authoritative source for research information and outputs is Elsevier Scopus, with researcher profile verification from the Deanship of Scientific Research.
المخرجات
Research outputs
Articles, reviews, conference papers and book chapters, indexed by DOI and linked to University researchers.
ABSTRACT Rheumatoid arthritis (RA) is a chronic inflammatory condition that affects millions of people globally, often leading to morbidity. Recent research highlights the potential of natural products in managing arthritis symptoms and modifying disease progression. Among these, Melaleuca alternifolia oil (MAO) has emerged as a promising therapeutic option due to its anti‐inflammatory and analgesic properties. A total of 36 Sprague–Dawley rats weighing between 200 and 220 g were divided into six groups ( n = 6). On day 0, arthritis was induced by CFA. On day 8, treatment started and lasted till day 28. Paw edema and arthritic score were measured. Moreover, hematological, histological, and biochemical parameters were evaluated. The mRNA expression levels of anti‐inflammatory cytokine IL‐4 and pro‐inflammatory cytokines such as TNF‐α, IL‐6, NF‐κB, and IL‐1β were measured using real‐time polymerase chain reaction (qPCR). ELISA was used to detect PGE2 levels. Network pharmacology was used to evaluate the hub genes between the phytocompounds and rheumatoid arthritis. Molecular docking and scoring calculations were done for the top matched hub genes for moderate confirmations between phytocompounds and targets. GC–MS analysis was also performed to identify potential anti‐inflammatory constituents present in the plant oil. Treatment with MAO effectively reduced paw edema and swelling. Histopathological examinations demonstrated significant improvement in the treatment groups. Biochemical parameters such as creatinine, urea, alanine aminotransferase (ALT), and alkaline phosphatase (ALP) did not significantly alter, and hematological parameters such as red blood cells (RBC), white blood cells (WBC), hemoglobin (Hb), and platelet count were restored in the treated group. The mRNA expression of anti‐inflammatory cytokines, including IL‐4, was upregulated, and pro‐inflammatory biomarkers such as TNF‐α, IL‐1β, IL‐6, and NF‐κB were significantly downregulated in the arthritic control group. Furthermore, treatment with MAO significantly reduced PGE2 levels. Network pharmacology indicated the hub genes and several biological processes, molecular functions, cellular components, and KEGG pathways that are involved in rheumatoid arthritis. Molecular docking was performed against hub genes such as AKT1, BCL‐2, MAPK3, and MMP9 that are involved in various pro‐inflammatory cytokine formation and pathophysiology of rheumatoid arthritis. GC–MS analysis of the plant's oil revealed the presence of numerous anti‐inflammatory and antirheumatic phytochemicals. MAO possesses considerable anti‐arthritic properties by downregulating pro‐inflammatory biomarkers such as IL‐1β, NF‐κB, IL‐6, TNF‐α, and upregulating anti‐inflammatory IL‐4. Further investigations are needed to explore its potential as a natural therapeutic option for treating RA.
tea tree oilrheumatoid arthritisanti-inflammatory activityCFA-induced arthritis
Ubiquitin machinery is an essential regulatory system that maintains protein stability, degradation, and signalling by balancing ubiquitination and deubiquitination. In addition to its classical function in protein tagging for proteasomal degradation, ubiquitin has several essential cellular functions, including cell-cycle regulation, DNA repair, immunomodulation, intracellular signalling, and cellular stress responses. Abnormal regulation of this highly ordered system has been implicated in the pathogenesis of cancer, neurodegenerative diseases, infectious diseases, metabolic dysfunction, and autoimmunity. Recent developments in structural biology, chemical biology, and proteomics have increased our understanding of ubiquitin signalling and identified new therapeutic targets by revealing context-specific interactions within nodes of the ubiquitinproteasome system. Future approaches to restore proteostasis involve selective inactivation of proteasomal subunits, E3 ligases, and deubiquitinating enzymes (DUBs), as well as novel modalities such as proteolysistargeting chimeras (PROTACs) and molecular glues that redirect ubiquitin-dependent degradation of diseaserelevant proteins. Although preclinical and early clinical studies have demonstrated target specificity, longterm safety remains a challenge for clinical translation. This review provides an overview of ubiquitin's pathophysiological functions in key human diseases, therapeutic interventions, and the potential of ubiquitin-based therapeutic strategies for precision medicine and targeted drug therapy.
International Journal of Research in Dermatology · vol. 12 (2) · 185-192
Impetigo is a common bacterial skin infection that primarily affects children, although it can occur in individuals of all ages. Despite its widespread prevalence and significant public health impact, a comprehensive evaluation of the most influential research on impetigo is lacking. This study aims to identify the 50 most-cited publications on impetigo and analyze trends in authorship, institutional contributions, study designs, and collaborative networks. A total of 2,126 articles were retrieved from Web of Science, of which 1,596 met the inclusion criteria. Subsequently, the articles were sorted in descending order based on citation count. Data extracted from each article included the title, authors, citation counts, study design, funding sources, and institutional collaborations. The years of publication varied from 1965 to 2019. The research output is largely driven by institutions in Australia, Japan, and the USA, with the University of Melbourne and Keio University being major contributors, and Steer. being the most frequently listed author, contributing to 8 highly cited articles. About 30–35% of the studies’ objectives centered on the pathophysiology and molecular mechanisms of bacterial skin infections, 20–25% on disease burden and epidemiology, and 20–25% focused on antimicrobial resistance and treatment methods. This bibliometric analysis provides a comprehensive evaluation of the most influential research on impetigo, highlighting key authors, institutions, and publication trends.
Learning disabilities (LD) present substantial challenges for both affected individuals and society, often going under-recognized, leading to delays in diagnosis and inadequate interventions. These conditions are complex and caused by a mix of genetics, environment, and brain function. This can affect the sensory and mental information during processing, making learning more difficult. A systematic review of 19 selected studies was conducted using databases such as PubMed, Embase, Cochrane Library, and Web of Science. Studies were evaluated for risk of bias, and findings were synthesized to offer an integrated understanding of the etiology, pathophysiology, diagnostic complexities, and treatment strategies associated with LD. Key genetic and environmental risk factors were identified, and diagnostic challenges were explored, with an emphasis on the role of neurocognitive assessments and educational tools for accurate identification. The effectiveness of different treatments, such as educational programs, cognitive therapy, and novel technologies, was also assessed in terms of how well they help improve learning outcomes. The information processing theory was examined in depth, illustrating how disruptions in the processing of sensory and cognitive stimuli contribute to the learning difficulties observed in LD. The review also emphasizes the need for a team effort, bringing together parents, teachers, healthcare workers, and communities. This might provide vital support for people with LD. Advances in educational technology and cognitive training offer promising avenues for improving information processing and, consequently, educational outcomes. A holistic approach to diagnosis and intervention is essential for optimizing the quality of life and educational success of individuals with LD.
Journal of Medical Case Reports · vol. 19 (1) · 144-144
BACKGROUND: Acute compartment syndrome occurs because of increased pressure within the fascial compartment, resulting in tissue ischemia. This surgical emergency, usually resulting from severe injury, is characterized by rapidly developing pain and swelling of the extremities. This case report aims to raise awareness among physicians by emphasizing the importance of high clinical sense in the diagnosis of compartment syndrome. CASE PRESENTATION: This report describes a 25-year-old Saudi male who presented to the emergency department with a 1-week history of left leg pain. The pain suddenly worsened to severe anterior leg pain and swelling after he rapidly climbed multiple stairs. Acute compartment syndrome in the anterior compartment with rhabdomyolysis was diagnosed. Urgent fasciotomy was performed and the patient recovered gradually. CONCLUSION: This report presents an exceptional case of acute myonecrosis in a patient with non-sickle cell disease, involving acute compartment syndrome in the anterior compartment, and rhabdomyolysis, which led to compartment syndrome.
BACKGROUND AND RATIONALE: The incidence and mortality of breast cancer (BC) continue to increase, making it a matter of public health concern worldwide. Despite the various strides made in breast cancer (BC) research, the molecular mechanisms driving its progression remain incompletely understood, particularly the role of key regulatory genes in tumor development and therapy resistance. TGFβ-1, IL19, CXCR4, BMP1, VCAN, and WNT2 have been implicated to be instrumental to critical oncogenic pathways; however, their cumulative contribution toward the pathophysiology of BC has not yet been investigated. Therefore, the present study utilizes an integrative bioinformatics approach to decipher their functional relevance, providing a basis for targeted therapies. METHODS AND ANALYTICAL APPROACH: TGF-β1, IL19, CXCR4, BMP1, VCAN, and WNT2 are among the important genes in BC that we have studied in great detail using bioinformatics techniques that detail differential gene expression analysis for their dysregulation in BC. Their broader oncogenic implications were then clarified by performing pan-cancer and pathway enrichment analyses. Molecular docking studies were employed to comprehend the functional interactions and potential therapeutic targets in protein-protein interaction (PPI) networks. KEY FINDINGS: It is demonstrated by our study that TGFβ-1 and CXCR4 are critical factors in the tumorigenesis of BC and their inhibition shows interference with tumor-associated pathways in a synergistic way. Computational modelling suggests that concomitant inhibition of these two targets, with D4476 and AMD3100, may show therapeutic value through modulation of certain key signalling cascades. CONCLUSION AND SIGNIFICANCE: This study provide new insights into the molecular basis of BC and support the idea of targeting TGFβ-1 and CXCR4 together for therapy. The above findings lay the foundation for future in vitro and in vivo experiments aimed at demonstrating that inhibition of both factors would be a viable strategy to improve the therapeutic outcome in BC.
• The pathogenesis of the disease multiple sclerosis (MS) is not well understood, but there are several existing theories. • MS is a demyelinating disease affecting the neurons of the central nervous system due to an immune-mediated process and leading to different neurological manifestations. • Its etiology is due to a network of interactions between genetic, immune, and environmental factors. • This comprehensive review paper offers recent insight through MS’s clinical manifestations, epidemiology, pathogenesis, and therapies, shedding light on some futuristic treatments for this disease. Multiple sclerosis (MS) is a chronic, immune-mediated neurological disorder that continues to challenge both researchers and clinicians. While advances in understanding its pathophysiology have led to improved disease-modifying therapies, these treatments primarily focus on immunosuppression and relapse prevention, leaving progressive forms of MS with limited options. Neurodegeneration, myelin loss, and long-term disability remain major hurdles, underscoring the urgent need for therapies that go beyond symptom management to actively repair damage and alter disease progression. With emerging breakthroughs in regenerative medicine, including stem cell-based therapies and novel immune-targeting treatments, we are entering a new era of MS research that prioritizes neuroprotection and repair. This review explores the latest insights into MS classification, pathogenesis, and treatment approaches, with a particular focus on cutting-edge therapies that hold the potential to shift MS care from disease suppression to long-term recovery. By bridging research and clinical application, this study aims to highlight the most promising avenues for future innovation and improved patient outcomes.
Fox-Fordyce disease (FFD) is a rare, chronic skin disorder affecting apocrine sweat glands, predominantly in women. It manifests as pruritic, dome-shaped papules in areas such as the axillae and pubic region. Treatment remains challenging, with limited success from conventional therapies. We report two cases of Saudi women aged 27 and 28 years presenting with hyperpigmented axillary papules and mild pruritus, consistent with FFD. One patient had no comorbidities, while the other had a known history of sickle cell anemia. Both cases were managed with laser therapy (erbium:yttrium aluminum garnet (YAG) in case 1 and ablative CO₂ in case 2) using precise protocols and follow-up plans. Clinical images demonstrated visual improvement post treatment. Adjunctive topical therapy was administered to manage inflammation and prevent hyperpigmentation. The cases underscore the typical presentation of FFD and the potential efficacy of laser-based interventions, even in patients with complex medical histories. Notably, the presence of sickle cell anemia did not exacerbate FFD manifestations, supporting the current treatment modalities. While hormonal therapy was not employed, its relevance remains a subject for future exploration. Laser therapy offers a promising approach for managing refractory FFD. Further studies are warranted to evaluate long-term outcomes and explore hormone-modulating strategies tailored to FFD's pathophysiology.
Journal of Advanced Trends in Medical Research · vol. 2 (2) · 270-278
Abstract Background: Hypertrophic cardiomyopathy (HCM) is when the heart muscle becomes thickened, which affects the function of the heart. It affects approximately 1 in 500 individuals in the general population. It is a multifactorial nature but is mainly caused by abnormal genes in the heart muscles. Many patients with HCM are non-symptomatic, and it is diagnosed typically with echocardiogram. HCM is marked by left ventricular hypertrophy, myocardial fibrosis and elevated risk of sudden cardiac death. The goal is to create a comprehensive analytical framework that clarifies the intricate relationships that exist between molecular pathways, environmental influences, genetic variations and clinical outcomes in HCM. Methods: We analysed 50 HCM patients using network analysis and structural equation modelling. We modelled HCM as a complex biological system using multilayered network analysis. Clinical symptoms, environmental triggers, molecular and cellular processes and genetic predisposition are interconnected in this framework. These layers were linked to uncover disease-supporting hubs, bottlenecks and subnetworks. Integrative approaches provide systems-level knowledge of HCM pathophysiology beyond reductionist, single-factor models. Results: The SEM revealed significant gene-environment interactions, with sarcomere mutations driving disease through sarcomere dysfunction and energy depletion, while environmental factors (exercise, diet) modulated progression through hypertrophic signalling. The model improved risk stratification accuracy (82% vs. 65% in traditional models) and identified three phenotypic subtypes. Conclusion: The multifaceted character of HCM, where environmental factors and genetic abnormalities interact to define disease progression, is highlighted by this study. By including these elements, risk assessment is improved and tailored care is informed.
Abstract Background The inflammation plays a role in the pathophysiology of type‐2 diabetes progression, and the mechanism remains unclear. The systemic immune‐inflammation index (SII) is a novel inflammatory marker for type 2 diabetes patients and integrates multiple indicators in complete blood counts and routine blood tests. Aim Since there is no international diagnostic standard for dry eye disease (DED), this study uses low‐cost inflammatory blood biomarkers to investigate the correlation between SII and DM2–DED and determine the diagnosis indices of other biomarkers in DM2–DED. Methodology A case‐control retrospective analysis of totel patients n = 293 randomly selected and categorized into four groups: DED, DM2, DM2‐DED, and healthy subjects. Demographic and blood biomarker variables were classified as categorical and continuous variables. The platelet‐to‐lymphocyte ratio (PLR), lymphocytes‐to‐lymphocyte ratio, neutrophil‐to‐lymphocyte ratio (NLR), and SII were calculated platelet count multiply by NLR and analyzed for their correlation for all groups. Results Focusing on DM2‐DED patients was more common in females, 59.6%, than in males, 40.2%. The mean ages were 60.7 ± 11.85 years, a statistically significant difference with all groups. In the study group DM2‐DED, there was an increase in all blood markers compared to all remaining groups except PLR. Only neutrophil, hemoglobin A1c (HbA1c), and fasting blood sugar levels were statistically significant differences in DM2‐DED patients (p > 0.001, p < 0.001, and p < 0.001, respectively) compared to all groups. There was a positive correlation between HbA1c and PLR, HbA1c and NLR, and HbA1c and SII (r = 0.037, p = 0.705; r = 0.031, p = 0.754; and r = 0.066, p < 0.501, respectively) in the DM2‐DED group. Conclusion This study demonstrated that elevated SII values were linked to elevated HbA1c in DM2‐DED patients. The potential of SII and HbA1c as early diagnostic indicators for ocular problems associated with diabetes mellitus is highlighted by their favorable connection in diagnosing DM2‐DED.
Background: Bronchial asthma is a persistent inflammatory respiratory condition that restricts the passage of air and causes hyperresponsiveness. Chronic asthma can be classified into three categories: mild, moderate, and severe. Remodeling took place as the extracellular matrix accumulated in the walls of the airways. Inflammation occurs as a result of the damage caused by matrix metalloproteinase-2 (MMP-2) to basement membrane type IV collagen. The severity of asthma may be associated with miR-196a2. The objective of our study was to investigate the underlying mechanisms and clinical relevance of miR-196a2 and MMP-2 serum levels in relation to the severity of asthma. Methods: This study recruited 85 controls and 95 asthmatics classified as mild, moderate, or severe. Expression of miR-196a2 was measured by quantitative reverse transcriptase PCR. Using the enzyme-linked immunosorbent assay (ELISA), MMP-2, IL-6, and total immunoglobulin E (IgE) levels in the serum of asthmatics of various grades were compared to a control group. MMP-2's diagnostic and prognostic potential was determined using ROC curve analysis. This study also measured blood Eosinophils and PFTs. We examined MMP-2's connections with IgE, blood Eosinophils, and PFTs. Results: The current investigation found that miR-196a2 expression was significantly higher in the control group than in asthmatic patients as a whole. The study found that severe asthmatics had higher MMP-2, IL-6, and IgE serum levels than healthy controls. We identified the MMP-2 serum concentration cutoff with great sensitivity and specificity. Significant relationships between MMP-2 serum level and miR-196a2 expression in the patient group with severe asthmatics were found. The MMP-2, IL-6, and IgE serum levels were considerably higher in mild, moderate, and severe asthmatics than controls. The miR-196a2 expression and MMP-2 serum concentration correlated positively with IgE and blood eosinophils % and negatively with all lung function tests in the asthmatic patient group.Conclusion: the study revealed that the elevated miR-196a2 expression and serum concentration of MMP-2, IL-6, and IgE associated with elevated blood eosinophils % is associated with pathophysiology and degree of asthma severity. The miR-196a2 expression and MMP-2 serum concentration have a promising diagnostic and prognostic ability in bronchial asthma.
Both adults and children are regularly afflicted by infectious illnesses. We now have a better understanding of their epidemiology, pathophysiology, prevention, and treatment because of new diagnostic techniques. Recently, emerging infections have surfaced, prompting health officials to issue warnings. Furthermore, novel anti-microbial therapies have been identified; however, because of the potential for adverse effects on antimicrobial resistance, it is critical to understand when to utilize these therapies in order to prevent overuse and misuse. In addition, new vaccinations have entered the market, and it is crucial that medical professionals understand how they may affect public health. Also the use of prebiotics and probiotics has emerged now as a preventive measure for pediatric infectious diseases.
Non-alcoholic fatty liver disease (NAFLD) is linked to type 2 diabetes mellitus (T2DM), obesity, and insulin resistance. The Rho/ROCK pathway had been involved in the pathophysiology of diabetic complications. This study was designed to assess the possible protective impacts of the Rho/Rho-associated coiled-coil containing protein kinase (Rho/ROCK) inhibitor fasudil against NAFLD in T2DM rats trying to elucidate the underlying mechanisms. Animals were assigned into control rats, non-treated diabetic rats with NAFLD, and diabetic rats with NAFLD that received fasudil treatment (10 mg/kg per day) for 6 weeks. The anthropometric measures and biochemical analyses were performed to assess metabolic and liver function changes. The inflammatory and oxidative stress markers and the histopathology of rat liver tissues were also investigated. Groups with T2DM showed increased body weight, serum glucose, and insulin resistance. They exhibited disturbed lipid profile, enhancement of inflammatory cytokines, and deterioration of liver function. Fasudil administration reduced body weight, insulin resistance, and raised liver enzymes. It improved the disturbed lipid profile and attenuated liver inflammation. Moreover, it slowed down the progression of high fat diet (HFD)-induced liver injury and reduced the caspase-3 expression. The present study demonstrated beneficial amelioration effect of fasudil on NAFLD in T2DM. The mechanisms underlying these impacts are improving dyslipidemia, attenuating oxidative stress, downregulated inflammation, improving mitochondrial architecture, and inhibiting apoptosis.
International Journal of Community Medicine and Public Health · vol. 9 (9) · 3613-3613
Shock is a clinical syndrome that results from lack of oxygen utilization or supply to vital organs resulting in hypoxia. Shock is associated with significant morbidity and mortality as if not treated timely can lead to multiple organ failure and death. The mortality rate of shock ranges from 20% to 50%. Shock has several pathophysiologies including intracardiac etiologies such as myocardial infarction, myopathy, or severe arrhythmia which produce altered maturation and cause heart failure while loss of internal or external fluid due to trauma or bleeding often results in hypovolemia. Also, obstruction by extracardiac causes and activation of inflammatory cascade can induce shock. The purpose of this research is to review the available information about the classification, pathophysiology and principle of therapy of shock. The major classification of shock includes cardiogenic, hypovolemic, obstructive and distributive shock. Distributive shock is further divided into three subclasses of septic, anaphylactic and neurogenic shock. Haemorrhagic shock is also the sub-type of hypovolemic shock. Each class of shock requires a specific treatment and timely management to prevent any further complications. Constant examination, resuscitation and re-evaluation are important in therapy of shock. To treat hypotension and to increase cardiac output, vasopressor drugs and inotropic adrenergic drugs continue to be the most widely used therapies. Endogenous catecholamines such as epinephrine, norepinephrine, and dopamine among other vasopressors have been shown to be effective in treating various types of shocks that are controlled as part of treatment for shock. Early diagnosis and prompt treatment can help in prevention of complications of shock also enhancing the recovery of patients.
Journal of Biosciences and Medicines · vol. 07 (03) · 20-28
Stroke is a devastating disease with a complex pathophysiology; it ranks second to ischemic heart disease as a cause of death and long-term disability. Tissue damage results from diverse mechanisms with central involvement of free radicals’ overproduction that results in oxidative stress and hence contributes to brain damage. Free radicals [Reactive oxygen species/Reactive nitrogen species] play central a role in the diverse normal physiological processes and as defense mechanisms against harmful substances. When the rate of their production exceeds the anti-oxidant capacity of the body, oxidative stress occurs. Oxidative stress is implicated in the pathogenesis of various diseases including hypertension, atherosclerosis, diabetes mellitus and cancer; they mediate damage to cell structures, lipid peroxidation, protein denaturation, nucleic acid and DNA damage.